References
- Rinke A, Muller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID study group. J Clin Oncol 2009;27:4656–63.
- Caplin ME, Pavel M, Cwikla J, Phan AT, Raderer M, Sedlacková E, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. New Engl J Med 2014;371: 224–33.
- Janson ET, Sorbye H, Welin S, Federspiel B, Gronbaeck H, Hellman P, et al. Nordic Guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Acta Oncol 2014;53:1284–97.